The ability of a lymphoid cell population to be stimulated to incorporate radio-labeled thymidine by phytohemagglu-tinin (PHA) has been widely accepted as a ready measure of cellular immune competence. Persisting PHA responsiveness in lymphocytes from irradiated blood, in particular, has been taken as evidence that radiation does not protect against the hazard of graft-versus-host reaction (GVH) in blood transfusion. Our independent conclusion that radiation of blood under appropriate conditions does protect immunologically incompetent recipients against GVH made necessary an effort to resolve this apparent contradiction. Irradiated cells stimulated with either PHA or allogeneic leukocytes have been studied in terms of known radiation sensitivity curves for cellular proliferation. These studies permit the conclusion that PHA responsiveness is not a valid measure of the immunocompetence of irradiated cells. Since the ability to replicate seems much more radiosensitive than the ability to respond, tests such as PHA responsiveness which measure only the ability to recognize and react to a mitogenic stimulus lose their validity in this context.
1 December 2018 in Medical Devices: Evidence and Research
Purpose: This study supports the use of thin-film micro-electro-mechanical system (MEMS) airflow sensors in the forced oscillation technique. Materials and methods: The study employed static testing using air flow standards and computer-controlled sound attenuations at 8 Hz. Human feasibility studies were conducted with a testing apparatus consisting of a pneumotach and thin-film MEMS air flow sensors in series. Short-time Fourier transform spectra were obtained using SIGVIEW software. Results: Three tests were performed, and excellent correlations were observed between the probes. The thin-film MEMS probe showed superior sensitivity to higher frequencies up to 200 Hz. Conclusion: The results suggest that lower-cost thin-film MEMS can be used for forced oscillation technique applications (including home care devices) that will benefit patients suffering from pulmonary diseases such as asthma, COPD, and cystic fibrosis.
1 January 2014 in World Allergy Organization Journal
Further study delivery system of precipitation of micronsized particles of insoluble allergen in muscle for immunotherapy (IT) to PI urushiol and adapt it to treat allergy to PN.